ArticleFrontiers in microbiology2022
Effect of disease severity on the structure and diversity of the phyllosphere microbial community in tobacco.
Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 23 citations in OpenAlex.
- Mycobiome Simplification in Wheat Is Associated With the Pathogen Parastagonospora nodorum.Molecular ecology · 2026Article
- Microbial and metabolic responses of maize silage to leaf blight: implications for fermentation and protein stability.BMC plant biology · 2026Article
- Microbial Community Structure and Diversity of Endophytic Bacteria and Fungi in the Healthy and Diseased Roots ofMicroorganisms · 2025Article
- Integrated genomics, metagenomics and metatranscriptomics to reveal the biocontrol mechanism ofFrontiers in microbiology · 2025Article
- Temporal dynamics of walnut phyllosphere microbiota under synergistic pathogen exposure and environmental perturbation.Frontiers in microbiology · 2025Article
- Effects ofPeerJ · 2025Article
- Biological characteristics and metabolic phenotypes of different anastomosis groups of Rhizoctonia solani strains.BMC microbiology · 2024Article
- Microbial communities in the phyllosphere and endosphere of Norway spruce under attack byFrontiers in microbiology · 2024Article
- Structure and assembly process of skin fungal communities among bat species in northern China.Frontiers in microbiology · 2024Article
- Phyllospheric microbial community structure and carbon source metabolism function in tobacco wildfire disease.Frontiers in cellular and infection microbiology · 2024Article
- Unveiling the Potential ofJournal of fungi (Basel, Switzerland) · 2023Article
- Response of microbial communities in the tobacco phyllosphere under the stress of validamycin.Frontiers in microbiology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tobacco target spot is a serious fungal disease and it is important to study the similarities and differences between fungal and bacterial community under different disease severities to provide guidance for the biological control of tobacco target spot. In this study, tobacco leaves at disease severity level of 1, 5, 7 and 9 (S1, S5, S7, and S9) were collected, both healthy and diseased leaf tissues for each level were sampled. The community structure and diversity of fungi and bacteria in tobacco leaves with different disease severities were compared using high-throughput sequencing technology. The results indicated that there was a significant differences in the community structure of fungi and bacteria for both healthy and diseased samples depending on the disease severity. In both healthy and diseased tobacco leaves for all four different disease severities, the most dominant fungal phylum was Basidiomycota with a high prevalence of genus
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.